Researchers confirm newly developed inhaled vaccine delivers broad protection against SARS-CoV-2, variants of concern

Scientists who have developed an inhaled form of COVID vaccine have confirmed it can provide broad, long-lasting protection against the original strain of SARS-CoV-2 and variants of concern. The research reveals the immune mechanisms and significant benefits of vaccines being delivered directly into the respiratory tract, rather than by traditional injection.